Natural autoantibodies to Fcγ receptors in intravenous immunoglobulins

Journal of Clinical Immunology

Volumn 34, Issue SUPPL. 1, 2014, Pages

  Bouhlal, Hicham ^a,b   Martinvalet, Denis ^c   Teillaud, Jean Luc ^c,d,e   Fridman, Catherine ^c,d,e   Kazatchkine, Michel D ^f   Bayry, Jagadeesh ^c,d,e,g   Lacroix Desmazes, Sébastien ^c,d,e,g   Kaveri, Srini V ^c,d,e,g  

^a UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^b AMIENS UNIVERSITY HOSPITAL   (France)

^c INSERM   (France)

^d CENTRE DE RECHERCHE DES CORDELIERS   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f UNAIDS   (Switzerland)

^g NATIONAL INSTITUTE OF IMMUNOHAEMATOLOGY   (India)

Author keywords

Autoimmunity; Fc receptor; Intravenous immunoglobulin; IVIg; Natural autoantibodies

Indexed keywords

AUTOANTIBODY; CYTOKINE; FC RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

AFFINITY CHROMATOGRAPHY; AUTOIMMUNE DISEASES; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; INNATE IMMUNITY; JURKAT CELL LINE; METABOLISM; PROCEDURES;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; CHROMATOGRAPHY, AFFINITY; CYTOKINES; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOTHERAPY; JURKAT CELLS; RECEPTORS, IGG;

EID: 84905175087     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-014-0019-2     Document Type: Article

References (30)

1. Coutinho A, Kazatchkine MD, Avrameas S. Natural autoantibodies. Curr Opin Immunol. 1995;7:812-8. (Pubitemid 26038522)
2. Durandy A, Kaveri SV, Kuijpers TW, Basta M, Miescher S, Ravetch JV, et al. Intravenous immunoglobulins: understanding properties and mechanisms. Clin Exp Immunol. 2009;158:2-13.
3. Madi A, Bransburg-Zabary S, Kenett DY, Ben-Jacob E, Cohan IR. The natural autoantibody repertoire in newborns and adults. Adv Exp Med Biol. 2012;750:198-212.
4. Avrameas S, Selmi C. Natural autoantibodies in the physiology and pathophysiology of the immune system. J Autoimmun. 2013;41:46-9.
5. Saint-Remy JM. Autoantibodies to coagulation factors. Haemophilia. 2010;16:56-60.
6. Nimmerjahn F, Ravetch JV. FcγRs in health and disease. Curr Top Microbiol Immunol. 2011;350:105-25.
7. Ravetch JV, Bolland S. IgG FC receptors. Annu Rev Immunol. 2001;19:275-90. (Pubitemid 32368037)
8. Nimmerjahn F, Ravetch JV. Fcγ receptors as regulators of immune responses. Nat Rev Immunol. 2008;8:34-47.
9. Loone RJ, Huggins J. Use of intravenous immunoglobulin G (IVIG). Best Pract Res Clin Haematol. 2006;19:3-25. (Pubitemid 43118860)
10. Vani J, Elluru S, Negi VS, Lacroix-Desmazes S, Kazatchkine MD, Bayry J, et al. Role of natural antibodies in immune homeostasis: IVIg perspective. Autoimmun Rev. 2008;7:440-4.
11. Bonagura VR. Using intravenous immunoglobulin (IVIG) to treat patients with primary immune deficiency disease. J Clin Immunol. 2013;33:S90-4.
12. Damianovich M, Blank M, Raiter A, Hardy B, Shoenfeld Y. Antivascular endothelial growth factor (VEGF) specific activity of intravenous immunoglobulin (IVIg). Int Immunol. 2009;21:1057-63.
13. Dunn-Siegrist I, Leger O, Daubeuf B, Poitevin Y, Dépis F, Herren S, et al. Pivotal involvement of Fcγ receptor IIA in the neutralization of lipopolysaccharide signaling via a potent novel anti-TLR4 monoclonal antibody 15C1. J Biol Chem. 2007;282:34817-27. (Pubitemid 350232459)
14. Astier A, de la Salle H, de la Salle C, Bieber T, Esposito-Farese ME, Freund M, et al. Human epidermal Langerhans cells secrete a soluble receptor for IgG (Fc gamma RII/CD32) that inhibits the binding of immune complexes to Fc gamma R+ cells. J Immunol. 1994;152:201-12.
15. D'Arrigo C, Candal-Couto JJ, Greer M, Veale DJ,Woof JM. Human neutrophil Fc receptor-mediated adhesion under flow: a hollow fibre model of intravascular arrest. Clin Exp Immunol. 1995;100:173-9.
16. Vivier E, da Silva AJ, Ackerly M, Levine H, Rudd CE, Anderson P. Association of a 70-kDa tyrosine phosphoprotein with the CD16: zeta: gamma complex expressed in human natural killer cells. Eur J Immunol. 1993;23:1872-6. (Pubitemid 23236780)
17. Koenderman L, Hermans SW, Capel PJ, van de Winkel JG. Granulocyte-macrophage colony-stimulating factor induces sequential activation and deactivation of binding via a low-affinity IgG Fc receptor, hFc gamma RII, on human eosinophils. Blood. 1993;81:2413-9. (Pubitemid 23127079)
18. Bayry J, Negi VS, Kaveri SV. Intravenous immunoglobulin therapy in rheumatic diseases. Nat Rev Rheumatol. 2011;7:349-59.
19. Wong A, Kenny TP, Ermel R, RobbinsDL. IgG3 reactive rheumatoid factor in rheumatoid arthritis: etiologic and pathogenic considerations. Autoimmunity. 1994;19:199-210.
20. Boros P, Chen JM, Bona C, Unkeless JC. Autoimmune mice make anti-Fc gamma receptor antibodies. J Exp Med. 1990;171:1581-95. (Pubitemid 20167552)
21. Boros P, Odin JA, Chen J, Unkeless JC. Specificity and class distribution of Fc gamma R-specific autoantibodies in patients with autoimmune disease. J Immunol. 1994;152:302-6.
22. Sajedi V, Movahedi M, Aghamohammadi A, Gharagozlou M, Shafiei A, Soheili H, et al. Comparison between sensitivity of autologous skin serum test and autologous plasma skin test in patients with Chronic Idiopathic Urticaria for detection of antibody against IgE or IgE receptor (FcεRIα). Iran J Allergy Asthma Immunol. 2011;10:111-7.
23. Mannoor K, Xu Y, Chen C. Natural autoantibodies and associated B cells in immunity and autoimmunity. Autoimmunity. 2013;46:138-47.
24. Samuelsson A, Towers TL, Ravetch JV. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science. 2001;291:484-6. (Pubitemid 32097072)
25. Bierlinga P. Intravenous immunoglobulin for autoimmune thrombocytopenic purpura. Hum Immunol. 2005;4:387-94.
26. Rouard H, Tamasdan S, Moncuit J, Moutel S, Michon J, Fridman WH, et al. Fc receptors as targets for immunotherapy. Int Rev Immunol. 1997;16:147-85. (Pubitemid 28073175)
27. Sautès C, Galinha A, Bouchard C,Mazières N, Spagnoli R, Fridman WH. Recombinant soluble Fc gamma receptors: production, purification and biological activities. J Chromatogr B Biomed Appl. 1994;662:197-207. (Pubitemid 24377220)
28. Teillaud JL, Bouchard C, Astier A, Teillaud C, Tartour E, Michon J, et al. Natural and recombinant soluble low-affinity Fc gamma R: detection, purification, and functional activities. Immunomethods. 1994;4:48-64. (Pubitemid 24085010)
29. Galon J, Gauchat JF, Mazières N, Spagnoli R, Storkus W, Lötze M, et al. Soluble Fcgamma receptor type III (FcgammaRIII, CD16) triggers cell activation through interaction with complement receptors. J Immunol. 1996;157:1184-92.
30. de la Salle H, Galon J, Bausinger H, Spehner D, Bohbot A, Cohen J, et al. Soluble CD16/Fc gamma RIII induces maturation of dendritic cells and production of several cytokines including IL-12. Adv Exp Med Biol. 1997;417:345-52. (Pubitemid 27427766)